Dr. Dietz received his degrees in medicine and medical education from the University of New England. He completed his Pediatric Residency and Hematology and Oncology Fellowship at Oregon Health & Science University where he also served as chief resident.In 2020 Dr. Dietz joined the faculty of the University of Utah, where he is currently an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. Clinically, Dr. Dietz focuses on the care of pediatric and young adult patients with bone and soft tissue sarcoma, as well as children with retinoblastoma. He is the Associate Director of the Primary Children's Hospital Solid Tumor Program and leads the Comprehensive Retinoblastoma Program. Dr. Dietz is committed to delivering cutting edge clinical care, as well as providing patients with access to experimental therapeutics and discovery programs.�Dr. Dietz's research efforts include team science approaches to better understand the biology driving cancer progression and treatment resistance with a focus on translating this work into new therapies. He is a member of the Huntsman Cancer Institute's Experimental Therapeutics Program and actively involved in the development of early phase clinical trials through multiple cooperative consortia including the Children's Oncology Group, The Sunshine Project, the Pediatric Oncology Experimental Therapeutics Investigator's Consortium, and the Pediatric Early Phase Clinical Trial Network. Dr. Dietz is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Ewing Sarcoma, Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Aspiration.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. �Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). �He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. �Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. �For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. �This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. �His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. �Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. �To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Mark Fluchel is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Fluchel is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Histiocytosis, and Reticulohistiocytoma.

Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is rated as an Advanced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.

Saeed Arabi is a primary care provider, practicing in Internal Medicine in Salt Lake City, Utah. Dr. Arabi is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

Nicholas Whipple is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Whipple is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Glioma, Anemia, Sickle Cell Disease, and Hemolytic Anemia.

Zeinab Afify is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Afify is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are X-Linked Lymphoproliferative Disease, Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Allison Bock is a Hematologist and a Hematologist Oncology provider in Salt Lake City, Utah. Dr. Bock is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant. Dr. Bock is currently accepting new patients.

Ming Lim is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are Blood Clots, Hemophilia A, Thrombocytopenia, Von Willebrand Disease (VWD), and Bone Marrow Aspiration. Dr. Lim is currently accepting new patients.

Srinivas Tantravahi is a Hematologist in Salt Lake City, Utah. Dr. Tantravahi is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tantravahi is currently accepting new patients.

Boyu Hu is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Hu is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Hu is currently accepting new patients.

Narendranath Epperla is a Hematologist in Salt Lake City, Utah. Dr. Epperla is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Epperla is currently accepting new patients.

David Warner is a Hematologist Oncology provider in Murray, Utah. Dr. Warner has been practicing medicine for over 11 years and is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Dehydration, Febrile Neutropenia, Agranulocytosis, and Chronic Familial Neutropenia. Dr. Warner is currently accepting new patients.

Jessica Donigan is a Dermatologist in Murray, Utah. Dr. Donigan has been practicing medicine for over 12 years and is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Melanoma, and Bowen's Disease. Dr. Donigan is currently accepting new patients.

Jason Hadley is a Dermatologist in Bountiful, Utah. Dr. Hadley is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Actinic Keratosis, Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus. Dr. Hadley is currently accepting new patients.

Scott Samuelson is an Oncologist and a Hematologist in Bountiful, Utah. Dr. Samuelson is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Familial Colorectal Cancer, and Non-Hodgkin Lymphoma. Dr. Samuelson is currently accepting new patients.